<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2718">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03071510</url>
  </required_header>
  <id_info>
    <org_study_id>MOB-VTP-001</org_study_id>
    <nct_id>NCT03071510</nct_id>
  </id_info>
  <brief_title>Evaluation of the Atlas Genetics io® CTNG System</brief_title>
  <acronym>IO-CTNG</acronym>
  <official_title>IO-CTNG: A Multi-Centre Evaluation of the Atlas Genetics io® CTNG System Used in Centralised and Point of Care Settings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atlas Genetics Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Atlas Genetics Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to compare Atlas Genetics io® system results with those
      obtained from comparator devices.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2017</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic Accuracy compared to positive Composite Infected Status from comparator devices</measure>
    <time_frame>Up to 7 days</time_frame>
    <description>The assessment of the diagnostic accuracy of the study device as compared to positive Composite Infected Status from comparator devices</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Chlamydia Trachomatis</condition>
  <condition>Gonorrhea</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Atlas Genetics io® system</intervention_name>
    <description>Specimen Collection</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants over 14 years of age for whom testing for Chlamydia trachomatis and/or
        Neisseria gonorrhoeae is appropriate
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Symptomatic and asymptomatic individuals ≥14 years of age

        Exclusion Criteria:

          1. Treatment with antibiotics known to be effective against Chlamydia trachomatis and/or
             Neisseria gonorrhoeae within the previous 4 weeks before inclusion in the study.

          2. Unable to self-obtain a vaginal swab or urine sample of at least 30 mL
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>John Hladkiwskyj, B.Sc.</last_name>
    <email>john.hladkiwskyj@atlasgenetics.com</email>
  </overall_contact>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 1, 2017</lastchanged_date>
  <firstreceived_date>February 27, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Gonorrhea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
